CVRx, Inc. Interest Expense
CVRx, Inc. (CVRX) reported Interest Expense of $960.00 thousand for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-10.
Discontinued › Expense Statement
us-gaap:InterestExpense · last filed 2024-05-10
- CVRx, Inc. interest expense for the quarter ending 2024-03-31 was $960.00K, a 300.00% increase year-over-year.
- CVRx, Inc. interest expense for the quarter ending 2023-12-31 was $579.00K, a 250.91% increase year-over-year.
- CVRx, Inc. interest expense for the quarter ending 2023-09-30 was $499.00K.
- CVRx, Inc. interest expense for the quarter ending 2023-06-30 was $481.00K.
- CVRx, Inc. interest expense for fiscal 2023 was $1.80M, a 990.30% increase from fiscal 2022.
- CVRx, Inc. interest expense for fiscal 2022 was $165.00K, a 92.56% decline from fiscal 2021.
- CVRx, Inc. interest expense for fiscal 2021 was $2.22M, a 10.16% decline from fiscal 2020.
- CVRx, Inc. interest expense for fiscal 2020 was $2.47M.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month |
|---|---|---|---|---|
| 2024-03-31 | $960.00K 10-Q · filed 2024-05-10 | $1.54M derived: sum of 2 quarters · filed 2024-05-10 | $2.04M derived: sum of 3 quarters · filed 2024-05-10 | $2.52M derived: sum of 4 quarters · filed 2024-05-10 |
| 2023-12-31 | $579.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-09 | $1.08M derived: sum of 2 quarters · filed 2024-02-09 | $1.56M derived: sum of 3 quarters · filed 2024-02-09 | $1.80M 10-K · filed 2024-02-09 |
| 2023-09-30 | $499.00K 10-Q · filed 2023-10-31 | $980.00K derived: sum of 2 quarters · filed 2023-10-31 | $1.22M 10-Q · filed 2023-10-31 | $1.39M derived: sum of 4 quarters · filed 2024-05-10 |
| 2023-06-30 | $481.00K 10-Q · filed 2023-08-03 | $721.00K 10-Q · filed 2023-08-03 | $886.00K derived: sum of 3 quarters · filed 2024-05-10 | $886.00K derived: sum of 4 quarters · filed 2024-05-10 |
| 2023-03-31 | $240.00K 10-Q · filed 2024-05-10 | $405.00K derived: sum of 2 quarters · filed 2024-05-10 | $405.00K derived: sum of 3 quarters · filed 2024-05-10 | $405.00K derived: sum of 4 quarters · filed 2024-05-10 |
| 2022-12-31 | $165.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-09 | $165.00K derived: sum of 2 quarters · filed 2024-02-09 | $165.00K derived: sum of 3 quarters · filed 2024-02-09 | $165.00K 10-K · filed 2024-02-09 |
| 2022-09-30 | $0.00 10-Q · filed 2023-10-31 | $0.00 derived: sum of 2 quarters · filed 2023-10-31 | $0.00 10-Q · filed 2023-10-31 | $396.00K derived: sum of 4 quarters · filed 2023-10-31 |
| 2022-06-30 | $0.00 10-Q · filed 2023-08-03 | $0.00 10-Q · filed 2023-08-03 | $396.00K derived: sum of 3 quarters · filed 2023-08-03 | $1.01M derived: sum of 4 quarters · filed 2023-08-03 |
| 2022-03-31 | $0.00 10-Q · filed 2023-05-11 | $396.00K derived: sum of 2 quarters · filed 2023-05-11 | $1.01M derived: sum of 3 quarters · filed 2023-05-11 | $1.62M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $396.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-10 | $1.01M derived: sum of 2 quarters · filed 2023-02-10 | $1.62M derived: sum of 3 quarters · filed 2023-02-10 | $2.22M 10-K · filed 2023-02-10 |
| 2021-09-30 | $614.00K 10-Q · filed 2022-11-04 | $1.22M derived: sum of 2 quarters · filed 2022-11-04 | $1.82M 10-Q · filed 2022-11-04 | $2.44M derived: sum of 4 quarters · filed 2022-11-04 |
| 2021-06-30 | $608.00K 10-Q · filed 2022-08-01 | $1.21M 10-Q · filed 2022-08-01 | $1.82M derived: sum of 3 quarters · filed 2022-08-01 | $2.44M derived: sum of 4 quarters · filed 2022-08-01 |
| 2021-03-31 | $601.00K 10-Q · filed 2022-05-02 | $1.22M derived: sum of 2 quarters · filed 2022-05-02 | $1.84M derived: sum of 3 quarters · filed 2022-05-02 | $2.45M derived: sum of 4 quarters · filed 2022-05-02 |
| 2020-12-31 | $614.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22 | $1.24M derived: sum of 2 quarters · filed 2022-02-22 | $1.85M derived: sum of 3 quarters · filed 2022-02-22 | $2.47M 10-K · filed 2022-02-22 |
| 2020-09-30 | $621.00K 10-Q · filed 2021-11-08 | $1.24M derived: sum of 2 quarters · filed 2021-11-08 | $1.86M 10-Q · filed 2021-11-08 | |
| 2020-06-30 | $618.00K 10-Q · filed 2021-08-09 | $1.24M 10-Q · filed 2021-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |